CLRB News and Press, Cellectar Biosciences Inc. From 07/09/19

Acacia Communications (NASDAQ: ACIA ) +37%  on being acquired by Cisco. More news on: Acacia Communications, Inc., Camber Energy, Inc., Check-Cap Ltd., Stocks on the move, Read more ...

The FDA designates Cellectar Biosciences' (NASDAQ: CLRB ) lead candidate CLR 131 for Fast Track review for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL). More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ... ...

FLORHAM PARK, N.J., July 09, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the U.S. Food and Drug Administ...

Cellectar Biosciences (NASDAQ: CLRB ) is 5.1% lower postmarket after a shareholder filing to offer up to 6.02M common shares. More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Clinical stage biopharmaceutical company Cellectar Biosciences (NASDAQ: CLRB) has closed a registered direct offering sale of 1,982,000 common shares and concurrent private placement of 2,018,000 common shares with institutional investors. In conjunction with the offerings, the company issued ...

CIRCOR (NYSE: CIR ) +51%  on Crane buyout offer . More news on: CIRCOR International, Inc., JMU Limited, Biocept, Inc., Stocks on the move, Read more ...

FLORHAM PARK, N.J., May 21, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that initial results from the th...

FLORHAM PARK, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it closed its previously announc...

Gainers:  Eltek (NASDAQ: ELTK ) +70% . Iovance Biotherapeutics (NASDAQ: IOVA ) +33% . Adverum Biotechnologies (NASDAQ: ADVM ) +25% . Charah Solutions (NYSE: CHRA ) +19% . KEMET Corporation (NYSE: KEM ) +17% . Mirati Therapeutics (NASDAQ: MRTX ) +16% . Danaos Corporation (NYSE: D...

Cellectar Biosciences ( CLRB -25.4% ) obliterates yesterday's  24%  spike with its $10M direct stock offering to institutional investors. More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...